In addition, phalloidin staining of the cytoskeleton showed a gradual decline in microfilament density with increasing drug dose (Fig. 6D), indicating that statins not only inhibit NNMT expression but also the motility of hepatoma cells. The gene discussed is NNMT; the disease is hepatocellular carcinoma.